STERIS plc (STE)
| Previous Close | 210.09 |
| Open | 222.99 |
| Bid | 223.35 x 1300 |
| Ask | 223.64 x 800 |
| Day's Range | 215.14 - 226.99 |
| 52 Week Range | 195.47 - 254.00 |
| Volume | |
| Avg. Volume | 481,077 |
| Market Cap | 22.081B |
| Beta (5Y Monthly) | 0.81 |
| PE Ratio (TTM) | 39.27 |
| EPS (TTM) | 5.69 |
| Earnings Date | May 09, 2024 |
| Forward Dividend & Yield | 2.08 (0.99%) |
| Ex-Dividend Date | Jun 11, 2024 |
| 1y Target Est | 239.86 |
ZacksSteris (STE) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Steris (STE) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
ZacksSteris (STE) Matches Q4 Earnings Estimates
Steris (STE) delivered earnings and revenue surprises of 0% and 3.07%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewswireSTERIS Announces Financial Results for Fiscal 2024 Fourth Quarter and Full Year
Total fiscal 2024 revenue increased 12% to $5.5 billionTotal fiscal 2024 U.S. GAAP earnings per diluted share of $3.81; adjusted earnings per diluted share increased to $8.83Targeted restructuring plan announced DUBLIN, IRELAND , May 08, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 fourth quarter ended March 31, 2024. Total revenue for the fourth quarter of fiscal 2024 increased 10% to $1.5 billion compared with
